CIK 0000921299 · Non-accelerated filer<br>Smaller reporting company
KYNTRA BIO, INC.
Sign in to watch- Ticker
- KYNB
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Entity type
- operating
- EIN
- 770357827
- Phone
- 415-978-1200
- Business address
- 350 BAY STREET, SUITE 100 #6009, SAN FRANCISCO, CA, 94133
- Former names
- FIBROGEN INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2024-02-21 | Graham Juan CHIEF FINANCIAL OFFICER | Grant or award | +52,000 | 224,618 | ||
| 2024-02-21 | Graham Juan CHIEF FINANCIAL OFFICER | Grant or award · Stock Option (Right to Buy) | +260,000 | 260,000 | ||
| 2024-02-01 | Wettig Thane CEO | Shares withheld for taxes | −23,490 | $2.37 | $56K | 257,932 |
| 2023-12-22 | Wettig Thane CEO | Shares withheld for taxes | −819 | $0.76 | $622 | 281,422 |
| 2023-12-07 | Graham Juan Chief Financial Officer | Shares withheld for taxes | −1,085 | $0.62 | $668 | 172,618 |
| 2023-12-06 | Graham Juan Chief Financial Officer | Shares withheld for taxes | −15,573 | $0.58 | $9K | 173,703 |
| 2023-12-06 | Chung Christine SVP, China Operations | Shares withheld for taxes | −18,182 | $0.58 | $11K | 334,837 |
| 2023-12-06 | Wettig Thane CEO | Shares withheld for taxes | −1,680 | $0.58 | $974 | 282,241 |
| 2023-11-01 | Wettig Thane CEO | Shares withheld for taxes | −21,841 | $0.55 | $12K | 283,921 |
| 2023-09-22 | Wettig Thane Interim CEO | Shares withheld for taxes | −819 | $0.79 | $644 | 305,762 |
| 2023-09-07 | Graham Juan Chief Financial Officer | Shares withheld for taxes | −1,096 | $0.99 | $1K | 189,276 |
| 2023-09-06 | Graham Juan Chief Financial Officer | Shares withheld for taxes | −711 | $0.96 | $685 | 190,372 |
| 2023-09-06 | Wettig Thane Interim CEO | Shares withheld for taxes | −1,680 | $0.96 | $2K | 306,581 |
| 2023-09-06 | Eisner Mark EVP, Chief Medical Officer | Shares withheld for taxes | −1,860 | $0.96 | $2K | 159,917 |
| 2023-09-06 | Chung Christine SVP, China Operations | Shares withheld for taxes | −3,308 | $0.96 | $3K | 353,019 |
| 2023-09-01 | Eisner Mark EVP, Chief Medical Officer | Shares withheld for taxes | −1,085 | $1.06 | $1K | 161,777 |
| 2023-09-01 | Henderson Jeffrey William Director | Sale 10b5-1 | −2,000 | $1.03 | $2K | 28,866 |
| 2023-08-30 | Graham Juan Chief Financial Officer | Grant or award | +120,000 | 191,083 | ||
| 2023-08-30 | Graham Juan Chief Financial Officer | Grant or award · Stock Option (Right to Buy) | +220,000 | 220,000 | ||
| 2023-08-30 | Chung Christine SVP, China Operations | Grant or award | +120,000 | 356,327 |
Page 5 of 8 · 156 trades